OverviewSuggest Edit

Protea is a molecular information company that has developed a platform technology, which enables the direct analysis, mapping and display of biologically active molecules in living cells and tissue samples.The technology platform offers new capabilities useful to the pharmaceutical, diagnostic, clinical research, agricultural and life science industries.

TypePublic
Founded2001
HQMorgantown, US
Websiteproteabio.com
Employee Ratings3.1

Latest Updates

Employees (est.) (Jun 2017)39
Revenue (FY, 2016)$2.4 M(+23%)
Share Price (Apr 2020)$0
Cybersecurity ratingBMore

Key People/Management at Protea Biosciences Group

Patrick Gallager

Patrick Gallager

Board of Directors - Director
Leonard Harris

Leonard Harris

Board of Directors - Director
Stanley Hostler

Stanley Hostler

Board of Directors - Director
Ed Roberson

Ed Roberson

Board of Directors - Director
Steve Turner

Steve Turner

Chief Executive Officer/Chairman of the Board
Matthew Powell

Matthew Powell

Chief Scientific Officer
Show more

Protea Biosciences Group Office Locations

Protea Biosciences Group has an office in Morgantown
Morgantown, US (HQ)
1311 Pineview Dr #501
Show all (1)

Protea Biosciences Group Financials and Metrics

Protea Biosciences Group Revenue

Protea Biosciences Group's revenue was reported to be $2.45 m in FY, 2016 which is a 22.1% increase from the previous period.
USD

Revenue (Q2, 2017)

328.1k

Gross profit (Q2, 2017)

(61.4k)

Gross profit margin (Q2, 2017), %

(18.7%)

Net income (Q2, 2017)

(5.5m)

EBIT (Q2, 2017)

(1.4m)

Market capitalization (27-Apr-2020)

794.0

Closing stock price (27-Apr-2020)

0.0

Cash (30-Jun-2017)

82.7k

EV

12.2m
Protea Biosciences Group's current market capitalization is $794 .
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

713.0k834.3k1.2m1.8m2.0m2.4m

Revenue growth, %

45%13%22%

Cost of goods sold

871.9k721.7k1.7m

Gross profit

896.4k1.3m741.0k
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

215.4k179.5k224.0k165.5k481.6k278.0k178.5k468.1k346.6k517.6k408.9k511.8k458.1k475.3k581.8k519.9k354.8k328.1k

Cost of goods sold

139.8k166.4k205.0k204.4k489.6k468.8k287.4k389.5k

Gross profit

269.1k345.4k253.1k271.0k92.2k51.1k67.4k(61.4k)

Gross profit Margin, %

66%67%55%57%16%10%19%(19%)
Show all financial metrics

Protea Biosciences Group Cybersecurity Score

Cybersecurity ratingPremium dataset

B

80/100

SecurityScorecard logo

Protea Biosciences Group Online and Social Media Presence

Embed Graph

Protea Biosciences Group News and Updates

AzurRx BioPharma to Acquire Payment Rights to Lead Drug Candidate MS1819-SD from Protea Biosciences Group

Eliminates milestone and royalty payments to Protea Biosciences Group Eliminates milestone and royalty payments to Protea Biosciences Group

Protea Biosciences Group Frequently Asked Questions

  • When was Protea Biosciences Group founded?

    Protea Biosciences Group was founded in 2001.

  • Who are Protea Biosciences Group key executives?

    Protea Biosciences Group's key executives are Patrick Gallager, Leonard Harris and Stanley Hostler.

  • How many employees does Protea Biosciences Group have?

    Protea Biosciences Group has 39 employees.

  • What is Protea Biosciences Group revenue?

    Latest Protea Biosciences Group annual revenue is $2.4 m.

  • What is Protea Biosciences Group revenue per employee?

    Latest Protea Biosciences Group revenue per employee is $62.7 k.

  • Who are Protea Biosciences Group competitors?

    Competitors of Protea Biosciences Group include InnerSpace, Mapxus and uGRIDD.

  • Where is Protea Biosciences Group headquarters?

    Protea Biosciences Group headquarters is located at 1311 Pineview Dr #501, Morgantown.

  • Where are Protea Biosciences Group offices?

    Protea Biosciences Group has an office in Morgantown.

  • How many offices does Protea Biosciences Group have?

    Protea Biosciences Group has 1 office.